C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2002
08/08/2002	WO2002061140A2 Competitive population normalization for comparative analysis of nucleic acid samples
08/08/2002	WO2002061139A2 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
08/08/2002	WO2002061138A1 Methods for detection of chloral hydrate in dichloroacetic acid
08/08/2002	WO2002061137A2 Compositions and methods for enhancing polynucleotide amplification reactions
08/08/2002	WO2002061135A2 Dna array sequence selection
08/08/2002	WO2002061134A2 Reagents and methods for identifying and modulating expression of tumor senescence genes
08/08/2002	WO2002061133A2 Nucleic acid detection using structured probes
08/08/2002	WO2002061132A1 Antisense modulation of chk2 expression
08/08/2002	WO2002061131A2 Human single nucleotide polymorphisms
08/08/2002	WO2002061130A2 Methods and reagents for analysis of rna structure and function
08/08/2002	WO2002061129A2 Oligonucleotide identifiers
08/08/2002	WO2002061128A2 Method of determining a chemotherapeutic regimen based on ercc1 expression
08/08/2002	WO2002061127A2 Arrayed polynucleotides and their use in genome analysis
08/08/2002	WO2002061126A2 The preparation of polynucleotide arrays
08/08/2002	WO2002061125A2 Immobilised aptamers
08/08/2002	WO2002061124A2 Analysis of methylation patterns in genomic dna using bisulfite treatment and fluorescence polarisation assay techniques
08/08/2002	WO2002061123A2 Method of analysing dna methylation using fluorescence polarisation
08/08/2002	WO2002061122A2 New method for genotype determination
08/08/2002	WO2002061121A2 Methods of analysis of nucleic acids
08/08/2002	WO2002061120A1 Method of evaluating ability of drug to induce enzyme in liver cells
08/08/2002	WO2002061119A1 Compositions for assaying glycoprotein
08/08/2002	WO2002061118A1 Method of evaluating the extent of reaching the intestine of bifidobacterium in fermented milk food or drink
08/08/2002	WO2002061117A1 Detection and identification of groups of bacteria
08/08/2002	WO2002061114A2 Water-soluble, fluorescent and mobile peptide substrates
08/08/2002	WO2002061112A2 Methods for detection of incorporation of a nucleotide onto a nucleic acid primer
08/08/2002	WO2002061110A2 Nucleic acid derivatives
08/08/2002	WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002	WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002	WO2002061085A2 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
08/08/2002	WO2002061084A2 Nt69, a nucleoside transporter family member and uses therefor
08/08/2002	WO2002061079A2 Biligands
08/08/2002	WO2002061078A2 Streptavidin aptamere
08/08/2002	WO2002061076A1 Adiponectin-associated protein
08/08/2002	WO2002061070A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
08/08/2002	WO2002061069A1 Runx3 gene showing anti-tumor activity and use thereof
08/08/2002	WO2002061054A2 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel
08/08/2002	WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/08/2002	WO2002061048A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
08/08/2002	WO2002061046A2 Novel nucleic acid and polypeptide molecules
08/08/2002	WO2002061045A2 Simplified method for indexing and determining the relative concentration of expressed messenger rnas
08/08/2002	WO2002061041A2 Solubility reporter gene constructs
08/08/2002	WO2002061038A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
08/08/2002	WO2002061033A2 Transfection of human embryonic stem cells
08/08/2002	WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
08/08/2002	WO2002060943A1 Human mitochondrial proteins and polynucleotides encoding the proteins
08/08/2002	WO2002060942A2 Protein modification and maintenance molecules
08/08/2002	WO2002060940A1 Juvenile hormone esterase
08/08/2002	WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
08/08/2002	WO2002060932A2 A serpin in bifidobacteria
08/08/2002	WO2002060931A2 A fimbria-like gene in bifidobacteria
08/08/2002	WO2002060927A1 Protein kinase signalling
08/08/2002	WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
08/08/2002	WO2002060915A1 Drug target isogenes: polymorphisms in the cytochrome p450, subfamily viia (cholesterol 7 alpha-monooxygenase), polypeptide 1 gene
08/08/2002	WO2002060584A2 Method for carrying out a biochemical protocol in continuous flow in a microreactor
08/08/2002	WO2002060575A2 Well-based biosensor for detecting molecular or cellular events
08/08/2002	WO2002060470A1 Pyk2 phosphorylation by her3 induces tumor invasion
08/08/2002	WO2002060340A2 Method for identifying maxi-k channel blockers
08/08/2002	WO2002060318A2 Detection of methylated cpg rich sequences diagnostic for malignant cells
08/08/2002	WO2002052275A3 Method for identifying blood cell hemostasis
08/08/2002	WO2002044200A3 Haplotypes of the edg1 gene
08/08/2002	WO2002043828A3 Microtiter plate format device and methods for separating differently charged molecules using an electric field
08/08/2002	WO2002036604A3 Diagnosis of diseases associated with the human c-mos gene
08/08/2002	WO2002034945A3 Estrogen receptor alpha variants and methods of detection thereof
08/08/2002	WO2002034937A3 Methods for detection of differences in nucleic acids
08/08/2002	WO2002034903A3 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/08/2002	WO2002034881A3 Compositions and methods for the discovery and selection of biological information
08/08/2002	WO2002029062A3 Cytokine proteins
08/08/2002	WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
08/08/2002	WO2002026192A3 Viruses targeted to hypoxic cells and tissues
08/08/2002	WO2002022836A3 A method for producing plants which are resistant to closteroviruses
08/08/2002	WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
08/08/2002	WO2002020833A3 Method for the specific determination of dna -sequences by means of parallel amplification
08/08/2002	WO2002020762A3 Tnf receptor-like molecules and uses thereof
08/08/2002	WO2002016398A3 Haplotypes of the bmpr2 gene
08/08/2002	WO2002016397A3 Haplotypes of the lipg gene
08/08/2002	WO2002013122A3 System and method for characterising and sequencing polymers
08/08/2002	WO2002012542A3 Enzyme substrate
08/08/2002	WO2002008450A3 Method for measuring jnk/sapk activity by phosphorylation of transcription factors
08/08/2002	WO2002002807A3 Diagnosis of diseases associated with cell signalling
08/08/2002	WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/08/2002	WO2002002579A3 Haplotypes of the eno3 gene
08/08/2002	WO2002000840A3 Human lyases
08/08/2002	WO2001096546A3 Protein phosphatases
08/08/2002	WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
08/08/2002	WO2001094635A9 Integrated active flux microfluidic devices and methods
08/08/2002	WO2001092574A3 Method for testing the inhibiting activity of a compound on an enzyme or for testing the resistance of an enzyme against inhibiting activity of a compound
08/08/2002	WO2001090330A3 AMINOACYL tRNA SYNTHETASES
08/08/2002	WO2001088101A3 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
08/08/2002	WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
08/08/2002	WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/08/2002	WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
08/08/2002	WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis
08/08/2002	WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002	WO2001079421A3 Apparatus and methods for testing effects of materials and surface coatings on the formation of biofilms
08/08/2002	WO2001077376A3 Diagnosis of diseases associated with metastasis
08/08/2002	WO2001076451A9 Diagnosis of diseases associated with metabolism
08/08/2002	WO2001075435A3 Fluorescence assay for gamma-secretase activity and inhibitors
08/08/2002	WO2001075171A3 Methods, compositions and kits for the detection and monitoring of breast cancer
08/08/2002	WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
08/08/2002	WO2001062968A3 Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods

1 ... 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 2275 2276 2277 2278 2279 2280 2281 2282 ... 3003